We did not perform “random sample sequencing” for sample validation or incorporate additional genetic markers to provide a more comprehensive genetic risk profile of T2DM, or conduct “functional studies” to investigate the impact of the E23K variant on KCNJ11 protein function and insulin secretion. This evidence concerns the gene INS and type 2 diabetes mellitus.